Although attenuation of ERK signal was only seen in ER- breast cancer cells, it is interesting that CSNK1G2 can target both PI3K/AKT/mTOR/S6K and ERK signal pathways depending on the characteristics of hormone receptor subtypes. Here, CSNK1G2 is linked to breast carcinoma.